Detailed answers about ISOMERASE THERAPEUTICS LIMITED, including incorporation, status, business activity, and accounts information.
When was ISOMERASE THERAPEUTICS LIMITED founded?
ISOMERASE THERAPEUTICS LIMITED was officially incorporated on 18 December 2012 and is registered under company number 08335008. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ISOMERASE THERAPEUTICS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ISOMERASE THERAPEUTICS LIMITED?
ISOMERASE THERAPEUTICS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ISOMERASE THERAPEUTICS LIMITED do?
ISOMERASE THERAPEUTICS LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is ISOMERASE THERAPEUTICS LIMITED's registered address?
The registered office address of ISOMERASE THERAPEUTICS LIMITED is FIRST FLOOR NEWNHAM BUILDING, CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, CAMBRIDGE, UNITED KINGDOM, CB10 1XL. This is the official address filed with Companies House for legal and statutory correspondence.
Is ISOMERASE THERAPEUTICS LIMITED financially stable?
The most recent accounts for ISOMERASE THERAPEUTICS LIMITED were made up to 31 December 2024, filed as SMALL. Next accounts are due by 30 September 2026.